Hepatic Venous Outflow Obstruction: Suggestion of a New Classification

Main Article Content

Santosh Man Shrestha

Keywords

ascites, bacterial infection, Budd–Chiari syndrome, hepatic vena cava syndrome, liver cirrhosis, sinusoidal obstruction syndrome

Abstract

Hepatic venous outflow obstruction (HVOO) is common in developing countries. It is a serious condition that clinically manifests with ascites from sinusoidal hypertension, and carries the risk of high mortality or development of liver cirrhosis. In the past, the eponym Budd–Chiari Syndrome (BCS) was used synonymously for HVOO. In the West, hepatic vein (HV) thrombosis caused by prothrombotic disorders is the main cause of HVOO. In the East, obliterative disease of hepatic portion of inferior vena cava induced by bacterial infection, now renamed hepatic vena cava syndrome, is the common cause of HVOO. These two diseases with different etiology, epidemiology, and natural history are at present grouped together under BCS causing much confusion. Sinusoidal obstruction syndrome, another important cause of HVOO at the level of the sinusoid and terminal HV, was left out in the classification of HVOO. In this article, the pathophysiology of sinusoidal hypertension is described, the term BCS is redefined, and a new classification of HVOO is suggested.

Abstract 2142 | PDF Downloads 464 HTML Downloads 3036 XML Downloads 101

References

1. Bradfield JWB. Liver sinusoidal cells. J Pathol. 1984;142:5–6. http://dx.doi.org/10.1002/path.1711420104
2. Lautt WW. Hepatic vasculature: A conceptual review. Gastroenterology. 1977;73:1163.
3. Greenway CV, Stark RD. Hepatic vascular bed. Physiol Rev. 1971;51:23.
4. Ludwig J, Hashimoto E, McGill DB, Heerden JA. Classification of hepatic venous outflow obstruction: Ambiguous terminology of the Budd-Chiari syndrome. Mayo Clin Proc. 1990;65:51–5. http://dx.doi.org/10.1016/S0025-6196(12)62109-0
5. Arora A, Tandon N, Sharma MP, Acharya SK. Constrictive pericarditis masquerading as Budd-Chiari syndrome. J Clin Gastroenterol. 1991;13(2):178–81. http://dx.doi.org/10.1097/00004836-199104000-00012
6. Shrestha SM, Shrestha S. Bacterial peritonitis in the hepatic inferior vena cava disease: A hypothesis to explain the cause of infection in high protein ascites. Hepatol Res. 2002;24:42–9. http://dx.doi.org/10.1016/S1386-6346(02)00018-9
7. Shrestha SM, Kage M, Lee BB. Hepatic vena cava syndrome: New concept of pathogenesis. Hepatol Res. 2017;47(7):603–615. http://dx.doi.org/10.1111/hepr.12869
8. Levy M, Waxler MJ. Sodium excretion in dogs with low-grade caval obstruction: Role of hepatic nerves. Am J Physiol. 1987;253:F672.
9. Gentil-Kocher S, Bernard O, Brunelle F, Hadchouel M, Maillard JN, Valayer J, et al. Budd-Chiari syndrome in children: Report of 22 cases. J Pediatrics. 1988;113(1):30–8. http://dx.doi.org/10.1016/S0022-3476(88)80524-9
10. Dixon Mann J, Walker Hall I. Obstruction of the inferior vena cava. Edinburgh MJ. 1904;16:56–62.
11. Shrestha SM. Liver cirrhosis and hepatocellular carcinoma in hepatic vena cava disease, a liver disease caused by obstruction of inferior vena cava. Hepatol Int. 2009;3:392–402. http://dx.doi.org/10.1007/s12072-009-9122-5
12. Stuart KL, Bras G. Veno-occlusive disease of the liver. Q J Med. 1957;26:291–315.
13. Stillman AE, Huxtable RJ, Consroe P, Kohnen P, Smith S. Hepatic veno-occlusive disease due to pyrrolizidine poisoning in Arizona. Gastroenterology. 1977;73:349–52.
14. Valla DC. Hepatic vein thrombosis (Budd-Chiari syndrome). Semin Liver Dis. 2002;22(1):5–14. http://dx.doi.org/10.1055/s-2002-23202
15. Shrestha SM. Liver cirrhosis in hepatic vena cava syndrome (or membranous obstruction of inferior vena cava). World J Hepatol. 2015;7(6):874–84. http://dx.doi.org/10.4254/wjh.v7.i6.874
16. Leopold LG, Parry TE, Storring FK. A change in sinusoid-trabecular structure of the liver with hepatic venous outflow block. J Pathol. 1970;100:87–98. http://dx.doi.org/10.1002/path.1711000203
17. Bolton C, Barnard WG. Pathological occurrences in liver in experimental venous stagnation. J Pathol Bacteriol. 1931;34:701. http://dx.doi.org/10.1002/path.1700340602
18. Kanel GC, Ucci AA, Kaplan MM, Wolfe HJ. A distinctive peri-venular hepatic lesion associated with heart failure. Am J Clin Pathol. 1980;73:235–9. http://dx.doi.org/10.1093/ajcp/73.2.235
19. Sherlock S. Liver in heart failure: Relation of anatomical, functional and circulatory changes. Br Heart J. 1951;13:273. http://dx.doi.org/10.1136/hrt.13.3.273
20. Chiari H. Ueber die selbstandie Phlebitis obliteraqns der Hauptstamme der Venae hepaticae als Todesursache. Beitr Z Pathol Anat U Z Allg Pathol. 1899;26:1–18.
21. Parkar RGF. Occlusion of the hepatic veins in man. Medicine. 1959;38:369–402. http://dx.doi.org/10.1097/00005792-195912000-00002
22. Tanaka M, Wanless IR. Pathology of the liver in Budd-Chiari syndrome: Portal vein thrombosis and histogenesis of veno-centric cirrhosis, veno-portal cirrhosis and large regenerative nodules. Hepatology. 1998;27:488–96. http://dx.doi.org/10.1002/hep.510270224
23. Kage M, Arakawa M, Kojiro M, Okuda K. Histopathology of membranous obstruction of the inferior vena cava in the Budd-Chiari syndrome. Gastroenterology.1992;102:2081–90. http://dx.doi.org/10.1016/0016-5085(92)90336-W
24. Chawla YK, Bodh V. Portal vein thrombosis. J Clin Exp Hepatol. 2015;5(1):22–40. http://dx.doi.org/10.1016/j.jceh.2014.12.008
25. McCuskey RS. Morphological mechanisms for regulating blood flow through hepatic sinusoids. Liver. 2000;20:3–7. http://dx.doi.org/10.1034/j.1600-0676.2000.020001003.x
26. Janssen HLA, Gaecia-Pagan J-C, Elias E, Mentha G, Hadengue A, Valla D-C. Budd-Chiari syndrome: A review by an expert panel. J Hepatol. 2003;38:364–71. http://dx.doi.org/10.1016/S0168-8278(02)00434-8
27. Valla DC. Budd-Chiari syndrome. In: Boyer TD, Wright TL, Manns MP, editors. Zakim and Boyer hepatology—Textbook of liver diseases. Philadelphia, PA: Saunders; 2006. p. 877–96.
28. Plessier A, Valla DC. Budd-Chiari syndrome. Semin Liver Dis. 2008;28:259–69. http://dx.doi.org/10.1055/s-0028-1085094
29. DeLeve LD, Valla CD, Garcia-Tsao G. Vascular disorders of the liver. AASLD practical guidelines. Hepatology. 2009;49(5):1729–63. http://dx.doi.org/10.1002/hep.22772
30. Okuda K. Membranous obstruction of the inferior vena cava (obliterative hepatocavopathy, Okuda). J Gastroenterol Hepatol. 2001;16:1179–83. http://dx.doi.org/10.1046/j.1440-1746.2001.02577.x
31. Budd G. Disease of the liver. London: John Churchill; 1845.
32. Raynaud. J hebd Med, Paris 1827; 5:173. Quoted by: Pleasants JH. Obstruction of inferior vena cava with a report of 18 cases. Johns Hopkins Hosp Rep. 1911;16:363–548.
33. Wilks S. Obstruction of hepatic veins and vena cava by fibrous deposit in the liver. Trans Path Soc Lond. 1862;13:122–4.
34. Osler W. Case of obliteration of vena cava inferior, with great stenosis of the orifices of hepatic veins. J Anat Physiol. 1878;13:291–305.
35. Valla D-C. Hepatic venous outflow obstruction etiopathogenesis: Asia versus the West. J Gastroenterol Hepatol. 2004;19:S204–11. http://dx.doi.org/10.1111/j.1400-1746.2004.03642.x
36. Dilawari JB, Bambery P, Chawla Y, Kaur U, Bhusnurmath SR, Malhotra HS, et al. Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of literature. Medicine. 1994;73:21–36. http://dx.doi.org/10.1097/00005792-199401000-00003
37. Singh V, Sinha SK, Nain CK, Bambery P, Kaur U, Verma S, et al. Budd-Chiari syndrome: Our experience of 71 patients. J Gastrotenterol Hepatol. 2000;15:550–4. http://dx.doi.org/10.1046/j.1440-1746.2000.02157.x
38. Wang ZG, Zhang FJ, Li XQ, Meng QY. Management of Budd-Chiari syndrome: What is the best approach? J Gastroenterol Hepatol. 2004;19(Suppl): S212–18. http://dx.doi.org/10.1111/j.1440-1746.2004.03677.x
39. Valla D, Hadengue A, el Yoounsi M, Azar N, Zeitoun G, Boudet MJ, et al. Hepatic venous outflow block caused by short-length hepatic vein stenosis. Hepatology. 1997;25:814–19. http://dx.doi.org/10.1002/hep.510250405
40. Murad SW, Valla D-C, de Groen PC, Zeitoun G, Hopmans JAM, Haagsma EB, et al. Determinants of survival and effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology. 2004;39:500–8. http://dx.doi.org/10.1002/hep.20064
41. Tandon BN, Nundy S. Outflow tract obstruction. In: Textbook of tropical gastroenterology. Delhi: Oxford University Press; 1988. p. 183–91.
42. Chawla YK. Budd-Chiari syndrome. In: Mahatab MA, Rahman S, editors. Liver: A complete book on hepato-pancreato-biliary diseases. India: Elsevier; 2009. p. 381–5.
43. Shrestha SM, Shrestha S. Hepatic vena cava syndrome: A common cause of liver cirrhosis in children in Nepal. Trop Gastroenterol. 2014;35(2):85–95. http://dx.doi.org/10.7869/tg.186
44. Nakamura T, Nakamura S, Aikawa T, Suzuki O, Onodera A, Karoji N. Obstruction of the inferior vena cave in the hepatic portion and the hepatic veins: Report of eight cases and review of the Japanese literature. Angiology. 1968;19:479–98. http://dx.doi.org/10.1177/000331976801900805
45. Yamamoto S, Yokoyama Y, Takeshige K, Iwatsuki S. Budd-Chiari syndrome with obstruction of the inferior vena cava. Gastroenterology. 1968;54:1070–84.
46. Takeuchi J, Takada A, Hasumura Y, Matsuda Y, Ikegami F. Budd-Chiari syndrome associated with obstruction of the inferior vena cava. Am J Med. 1971;51:11–20. http://dx.doi.org/10.1016/0002-9343(71)90319-6
47. Nakamura S, Takezawa Y. Obstruction of the inferior vena cava in the hepatic portion and hepatocellular carcinoma. Tohoku J Exp Med. 1982;138:119–20. http://dx.doi.org/10.1620/tjem.138.119
48. Datta DV, Saha S, Singh SA, Gupta BB, Aikat BK, Chutani PN. Clinical spectrum of Budd-Chiari syndrome in Chandigarh with particular reference to obstruction of intrahepatic portion of inferior vena cava. Indian J Med Res. 1972;60:385–401.
49. Madangopalan N, Solomon V, Jayanthi V, Raghuram K, Balakumar M, Kandasamy I, et al. Clinical spectrum of chronic Budd-Chiari syndrome and surgical relief for “coarctation” of the inferior vena cava. J Gastroenterol Hepatol. 1986;1:359–69. http://dx.doi.org/10.1111/j.1440-1746.1986.tb00776.x
50. Shrestha SM. Membranous obstruction of hepatic portion of the inferior vena cava: Is this an underdiagnosed entity in developing countries. Am J Gastroenterol. 1995;90(2):303–6.
51. Shrestha SM, Okuda K, Uchida T, Maharjan KG, Shrestha S, Joshi BL, et al. Endemicity and clinical picture of liver disease due to obstruction of the hepatic portion of the inferior vena cava in Nepal. J Gastroenterol Hepatol. 1996;11:170–9. http://dx.doi.org/10.1111/j.1440-1746.tb00056.x
52. Shrestha SM. Hepatic venous outflow obstruction in Nepal. Trop Gastroenterol. 1996;17:165–71.
53. Simson IW. Membranous obstruction of the inferior vena cava and hepatocellular carcinoma in South Africa. Gastroenterology. 1982;82:171–8.
54. Kew MC, McKnight A, Hodkinson J, Bukofzer S, Esser JD. The role of membranous obstruction of the inferior vena cava in the etiology of hepatocellular carcinoma in Southern African Blacks. Hepatology. 1989;9:121–5. http://dx.doi.org/10.1002/hep.1840090121
55. Awwad S. The Budd-Chiari syndrome. Egypt Med J. 1952;35:650–69.
56. Kimura C, Matsuda S, Koie H, Hirooka M. Membranous obstruction of the hepatic portion of the inferior vena cava: Clinical study of nine cases. Surgery. 1972;72:551–9.
57. Ono J, Sakoda K, Kawada T. Membranous obstruction of the inferior vena cava. Ann Surg. 1983;197:454–8. http://dx.doi.org/10.1097/00000658-198304000-00014
58. Wang Z-G. Management of Budd-Chiari syndrome: Experience from 430 cases. Asian J Surg. 1996;19:23–30.
59. Lee B-B, Villavicencio L, Kim YW, Do YS, Koh KC, Lim HK, et al. Primary Budd-Chiari syndrome: Outcome of endovascular management for suprahepatic venous obstruction. J Vas Surg. 2006;43(1):101–8. http://dx.doi.org/10.1016/j.jvs.2005.09.003
60. Okuda K, Kage M, Shrestha SM. Proposal of a new nomenclature for Budd-Chiari syndrome: Hepatic vein thrombosis versus thrombosis of the inferior vena cava at its hepatic portion. Hepatology. 1998;28:1191–8. http://dx.doi.org/10.1002/hep.510280505
61. Shrestha SM. Natural history of hepatic vena cava disease, the liver disease due to obstruction of hepatic portion of inferior vena cava. Hepatol Int. 2009;3:1–12. http://dx.doi.org/10.1007/s12072-009-913-2
62. Bras G, Jeliffe DB, Stuart KL. Veno-occlusive disease of the liver with non-portal type of cirrhosis occurring in Jamaica. Arch Pathol. 1954;57:285–300.
63. Dubrovinskii SB. The etiology of toxic hepatitis with ascites. In: Millenkov SM, Kizhaikin Y, editors. Collection of scientific papers on toxic hepatitis with ascites. Tashkent, USSR: Publishing House of the University of Central Asia; 1952. p. 9–25.
64. Mohabbat O, Younos MS, Merzad AA, Srivastava RN, Sediq GG, Aram GN. An outbreak of hepatic veno-occlusive disease in north-western Afghanistan. Lancet. 1976;2:269–71. http://dx.doi.org/10.1016/S0140-6736(76)90726-1
65. Tandon RK, Tandon BN, Tandon HD, Bhatia ML, Bhargava S, Lal P, et al. Study of an epidemic of veno-occlusive disease in India. Gut. 1976;17:849–55. http://dx.doi.org/10.1136/gut.17.11.849
66. Tandon HD, Tandon BN, Nayak NC. A pathological study of liver in an epidemic outbreak of veno-occlusive disease. Indian J Med Res. 1977;65:679–84.
67. Read AE, Weisner RH, LaBrecque DR, Tifft JG, Mullen KD, Sheer RL, et al. Hepatic veno-occlusive disease associated with renal transplantation and azathioprine therapy. Ann Intern Med. 1986;104:651–5. http://dx.doi.org/10.7326/0003-4819-104-5-651
68. Berk PD, Popper H, Krueger GRF, Decter J, Herzig G, Graw RG Jr. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation. Ann Intern Med. 1979;90:158–64. http://dx.doi.org/10.7326/0003-4819-90-2-158
69. DeLeve LD, Shulman HM, McDonald GB. Toxic injury to hepatic sinusoids: Sinusoidal obstruction syndrome (veno-occlusive disease). Semi Liver Dis. 2002;22:27–41. http://dx.doi.org/10.1055/s-2002-23204
70. Shrestha SM, Shrestha S. Hepatic vena cava disease: Etiologic relation to bacterial infection. Hepatol Res. 2007;37:196–204. http://dx.doi.org/10.1111/j.1872-034X.2007.00012.x
71. Pleasants JH. Obstruction of inferior vena cava with a report of 18 cases. Johns Hopkins Hosp Rep. 1911;16:363–548.
72. Khuroo MS, Datta DV. Budd-Chiari syndrome following pregnancy. Am J Med. 1980;68:113–21. http://dx.doi.org/10.1016/0002-9343(80)90180-1
73. Shrestha SM, Ghimire RK, Basnyat P, Pradhan V, Poudel V. Acute on chronic phenomenon in hepatic IVC obstruction: A case report. Trop Gastroenterol. 1999;20:182–4.
74. Shrestha SM. Pleural effusion in hepatic vena cava disease. Kathmandu University Med J. 2007;5(2):218–24.
75. Shrestha SM. Diagnosis of hepatic vena cava syndrome by ultrasonography and color Doppler based on new concept of its pathogenesis. EC Gastroenterol Dig Syst. 2017;2(1):256–70.
76. Epstein M. Functional renal abnormalities in cirrhosis: Pathophysiology and management. In: Zakim D, Boyer TD, editors. Hepatology a textbook of liver disease. 2nd ed. Vol. I. Philadelphia, PA: W.B. Saunders; 1990. p. 493–512.
77. Shrestha SM, Shrestha S, Shrestha A, Tsuda F, Endo K, Takahashi M, et al. High prevalence of hepatitis B virus infection and inferior vena cava obstruction among patients with liver cirrhosis or hepatocellular carcinoma in Nepal. J Gastroenterol Hepatol. 2007;22:1921–8. http://dx.doi.org/10.1111/j.1440-1746.2006.04611.x